Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $63.0450 (-0.86%) ($63.0450 - $63.6600) on Fri. Sep. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.56% (three month average) | RSI | 39 | Latest Price | $63.0450(-0.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.9% a day on average for past five trading days. | Weekly Trend | LGND declines -1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IVW(93%) XHB(86%) VFMO(84%) XAR(80%) SPY(79%) | Factors Impacting LGND price | LGND will decline at least -0.78% in a week (0% probabilities). UUP(-27%) URA(-20%) REMX(-18%) TBT(-17%) VIXM(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.78% (StdDev 1.56%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $60.9(-3.4%) | Resistance Level | $65.72 | 5 Day Moving Average | $64.26(-1.89%) | 10 Day Moving Average | $64.76(-2.65%) | 20 Day Moving Average | $65.72(-4.07%) | To recent high | -20.2% | To recent low | 0% | Market Cap | $1.013b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |